This is an HTML version of an attachment to the Freedom of Information request 'Industry, vaccines and patents (DG Trade)'.





Ref. Ares(2021)1485575 - 25/02/2021
Ref. Ares(2021)2029622 - 22/03/2021
Meeting with EFPIA on CAI 
Meeting date and place 
Meeting held on 26/01/2021 13:00 
Participating organisation(s) & representative(s) 
- - European Federation of Pharmaceutical Industries and Associations (TRN: 38526121292-88)  , 
Main issues discussed 
 The Commission met with EFPIA to discuss the recent conclusion in principle of the EU-China Comprehensive Agreement on Investment
(CAI). The Commission clarified the context and scope of the agreement and gave an overview of its content. 
Directorate or unit 
TRADE B/3 
Internal participants 
[Art. 4.1 (b)]
  TRADE  B/3  [Art. 4.1 (b)]
@ec.europa.eu)  Participant
[Art. 4.1 (b)]
 
TRADE  B/3  [Art. 4.1 (b)]
@ec.europa.eu) 
ParticipantNotetaker
[Art. 4.1 (b)]
 
TRADE  B/3  [Art. 4.1 (b)] @ec.europa.eu) 
Participant
[Art. 4.1 (b)]
  TRADE  E/3  [Art. 4.1 (b)]
@ec.europa.eu) 
Participant
Author(s) of minutes 
[Art. 4.1 (b)]
 
Validator and validation date 
[Art. 4.1 (b)]
 validated the minutes on 25/02/2021 15:49 
Minutes generated by EMT (Id:TRADE/1836)
Page 1 of 1